• Profile
Close

Expression of bone morphogenetic proteins in multiple sclerosis lesions

American Journal of Pathology Dec 19, 2018

Costa C, et al. - Researchers described the expression of bone morphogenetic proteins (BMPs) in chronic multiple sclerosis (MS) lesions and determined if their expression is relevant in MS in comparison with other demyelinating diseases. For this investigation, they included 42 MS lesions, 12 acute ischemic lesions, 8 progressive multifocal leucoencephalopathy lesions, and 10 CNS areas from 4 non-neuropathological patients. Findings revealed that the percentage of cells expressing BMPs, BMPRII, and pSMAD1/5/8 correlated with the inflammatory activity of MS lesions, and changes in the percentage of positive cells in MS were more relevant than in other white matter–damaging diseases. In active MS lesions, BMPs are increased, implying a possible role in MS pathogenesis.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay